Riskpilot← Back to searchSign inGet full accessDR. AASBØ AS
ASActiveOrg 918360603Huth Platå 6, 1678 KråkerøyMedical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
NOK 2,2M
-39% vs 2023
EBITDA margin
83.7%
+35% vs 2023
Equity ratio
93.2%
Financial strength
Net profit 2024
NOK 1,9M
+190% vs 2023
| Revenue | NOK 2,2M | -39% |
| EBITDA | NOK 1,9M | +35% |
| Net profit | NOK 1,9M | +190% |
| Total assets | NOK 6,9M | +23% |
| Equity | NOK 6,4M | +24% |
| Employees | 1 | — |
Legal name
DR. AASBØ AS
Org number
918360603
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. januar 2017
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet. Anestesiservice til forskjellige oppdragsgivere, samt undervisningsvirksomhet for helsepersonell. Videre skal selskapet investere i verdipapirer, både noterte og unoterte, samt investere i eiendom, både i norge og i utlandet.
Address
Huth Platå 6, 1678 Kråkerøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 550 | 5 189 | 5 653 | 3 681 | 2 245 |
| Staff expenses | −468 | −723 | −788 | −732 | −2 |
| EBITDA | 2 371 | 2 157 | 2 409 | 1 396 | 1 879 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 371 | 2 157 | 2 409 | 1 396 | 1 879 |
| Net financials | 59 | −0 | −1 964 | −442 | 404 |
| Profit before tax | 2 430 | 2 157 | 445 | 954 | 2 283 |
| Tax | 535 | 474 | 530 | 313 | 422 |
| Net profit | 1 895 | 1 682 | −85 | 641 | 1 861 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 106 | 7 418 | 5 693 | 5 611 | 6 911 |
| Equity | 3 339 | 4 121 | 4 036 | 5 177 | 6 438 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 767 | 3 297 | 1 657 | 434 | 472 |
| Total debt | 767 | 3 297 | 1 657 | 434 | 472 |
EBITDA margin
83.7%
This company
15.8%
Market median
+430% vs market
20202024
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
20202024
Return on equity
28.9%
This company
18.4%
Market median
+57% vs market
20202024
Net profit margin
82.9%
This company
8.1%
Market median
+923% vs market
20202024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2017 | |
| Chairman | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DR. AASBØ AS 
COLOSSEUM FAUST ASBoard members of DR. AASBØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Bache-Mathiesen | Board of Directors | 0 companies |
| Vidar Aasbø | Chairman | 0 companies |